Literature DB >> 19732752

Liganded RARalpha and RARgamma interact with but are repressed by TNIP1.

Igor Gurevich1, Brian J Aneskievich.   

Abstract

Nuclear receptor (NR) transcriptional activity is controlled by agonist binding and concomitant exchange of receptor-associating corepressor proteins for NR box-containing, receptor AF-2-targeting coactivator proteins. We report here that TNIP1 is an atypical NR coregulator. Requirements for TNIP1-RAR interaction-its NR boxes, ligand, and the receptor's AF-2 domain-are characteristic of coactivators. However, TNIP1 reduces RAR activity. Repression is partially relieved by SRC1, suggesting interference with coactivator recruitment as a mechanism of TNIP1 repression. TNIP1 does not bind RXRalpha and RARalpha AF-2 domain, necessary for that receptor's association with TNIP1, is insufficient to confer upon RXRalpha interaction with TNIP1. Preferential interaction of RARalpha over RARgamma with TNIP1 can be mapped to RARalpha ligand binding domain helices 5-9 and suggests regions outside the receptor helix 12 modulate interaction of NRs and NR box-containing corepressors. TNIP1 repression of RARs in the presence of RA places it in a small category of corepressors of agonist-bound NRs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732752      PMCID: PMC2759858          DOI: 10.1016/j.bbrc.2009.08.159

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Nuclear hormone receptors and gene expression.

Authors:  A Aranda; A Pascual
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

2.  Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements.

Authors:  B J Aneskievich; E Fuchs
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

3.  Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants.

Authors:  Anna N Moraitis; Vincent Giguère; Catherine C Thompson
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 4.  Overview of nomenclature of nuclear receptors.

Authors:  Pierre Germain; Bart Staels; Catherine Dacquet; Michael Spedding; Vincent Laudet
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

5.  Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1.

Authors:  Karen Heyninck; Marja M Kreike; Rudi Beyaert
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

6.  Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand.

Authors:  Herborg Hauksdottir; Behnom Farboud; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2002-12-23

7.  Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression.

Authors:  M Fukushi; J Dixon; T Kimura; N Tsurutani; M J Dixon; N Yamamoto
Journal:  FEBS Lett       Date:  1999-01-08       Impact factor: 4.124

8.  Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha.

Authors:  B F Tate; G Allenby; R Janocha; S Kazmer; J Speck; L J Sturzenbecker; P Abarzúa; A A Levin; J F Grippo
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

9.  Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis.

Authors:  P Dollé; E Ruberte; P Leroy; G Morriss-Kay; P Chambon
Journal:  Development       Date:  1990-12       Impact factor: 6.868

10.  Nuclear receptor corepressors.

Authors:  Mitchell A Lazar
Journal:  Nucl Recept Signal       Date:  2003-06-12
View more
  15 in total

1.  TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Brian J Aneskievich
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

Review 2.  New insights in the immunologic basis of psoriasis.

Authors:  Kristine E Nograles; Batya Davidovici; James G Krueger
Journal:  Semin Cutan Med Surg       Date:  2010-03

3.  PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Authors:  Igor Gurevich; Carmen Zhang; Priscilla C Encarnacao; Charles P Struzynski; Sarah E Livings; Brian J Aneskievich
Journal:  Biochim Biophys Acta       Date:  2011-10-07

4.  Retinoic acid signaling regulates Krt5 and Krt14 independently of stem cell markers in submandibular salivary gland epithelium.

Authors:  Timur M Abashev; Melissa A Metzler; Diana M Wright; Lisa L Sandell
Journal:  Dev Dyn       Date:  2017-02       Impact factor: 3.780

5.  TNIP1 is a corepressor of agonist-bound PPARs.

Authors:  Anthony M Flores; Igor Gurevich; Carmen Zhang; Vincent P Ramirez; Taylor R Devens; Brian J Aneskievich
Journal:  Arch Biochem Biophys       Date:  2011-09-22       Impact factor: 4.013

6.  TNIP1 reduction of HSPA6 gene expression occurs in promoter regions lacking binding sites for known TNIP1-repressed transcription factors.

Authors:  Vincent P Ramirez; Winfried Krueger; Brian J Aneskievich
Journal:  Gene       Date:  2014-11-12       Impact factor: 3.688

Review 7.  Emerging roles for TNIP1 in regulating post-receptor signaling.

Authors:  Vincent P Ramirez; Igor Gurevich; Brian J Aneskievich
Journal:  Cytokine Growth Factor Rev       Date:  2012-04-28       Impact factor: 7.638

8.  Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Charles P Struzynsky; Sarah E Livings; Brian J Aneskievich
Journal:  Gene       Date:  2012-12-08       Impact factor: 3.688

9.  DNA methylation of lipid-related genes affects blood lipid levels.

Authors:  Liliane Pfeiffer; Simone Wahl; Luke C Pilling; Eva Reischl; Johanna K Sandling; Sonja Kunze; Lesca M Holdt; Anja Kretschmer; Katharina Schramm; Jerzy Adamski; Norman Klopp; Thomas Illig; Åsa K Hedman; Michael Roden; Dena G Hernandez; Andrew B Singleton; Wolfgang E Thasler; Harald Grallert; Christian Gieger; Christian Herder; Daniel Teupser; Christa Meisinger; Timothy D Spector; Florian Kronenberg; Holger Prokisch; David Melzer; Annette Peters; Panos Deloukas; Luigi Ferrucci; Melanie Waldenberger
Journal:  Circ Cardiovasc Genet       Date:  2015-01-12

10.  Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.

Authors:  Lara Bossini-Castillo; Jose Ezequiel Martin; Jasper Broen; Carmen P Simeon; Lorenzo Beretta; Olga Y Gorlova; Madelon C Vonk; Norberto Ortego-Centeno; Gerard Espinosa; Patricia Carreira; Paloma García de la Peña; Natividad Oreiro; José Andrés Román-Ivorra; María Jesús Castillo; Miguel A González-Gay; Luis Sáez-Comet; Ivan Castellví; Annemie J Schuerwegh; Alexandre E Voskuyl; Anna-Maria Hoffmann-Vold; Roger Hesselstrand; Annika Nordin; Claudio Lunardi; Raffaella Scorza; Jacob M van Laar; Paul G Shiels; Ariane Herrick; Jane Worthington; Carmen Fonseca; Christopher Denton; Filemon K Tan; Frank C Arnett; Shervin Assassi; Bobby P Koeleman; Maureen D Mayes; Timothy R D J Radstake; Javier Martin
Journal:  Ann Rheum Dis       Date:  2012-08-15       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.